|Specialty||Retina & Vitreous|
|Medical School||Albert Einstein College of Medicine (M.D.) Stanford University (Ph.D.)|
|Residency||Washington University in St. Louis|
|Fellowship||Associated Retinal Consultants / William Beaumont Hospital|
|Special Interest||Adult and pediatric vitreoretinal diseases, including macular degeneration, diabetic eye disease, retinal vein occlusions, retinal detachments, proliferative vitreoretinopathy, macular holes and epiretinal membranes. Specialty interest in pediatric vitreoretinal diseases, including the surgical management of advanced retinopathy of prematurity, familial exudative vitreoretinopathy, Coats disease, persistent fetal vascular syndrome, and intraocular trauma; Scientific focus on developmental angiogenesis, with emphasis on the role of the Wnt Signaling pathway in developmental vascular diseases.|
|Publications||View on PubMed|
Eric D. Nudleman, M.D., Ph.D. is an Assistant Clinical Professor of Ophthalmology at UC San Diego Shiley Eye Institute. He joined UC San Diego (UCSD) after completing his fellowship in vitreoretinal surgery at the renowned William Beaumont Hospital. Prior to his fellowship, Dr. Nudleman graduated from Stanford University with bachelors and doctoral degrees. He earned his medical degree at Albert Einstein College of Medicine of Yeshiva University in New York then went on to Washington University School of Medicine in St. Louis, Missouri for his residency. Dr. Nudleman is the recipient of many prestigious honors such as the Ronald G. Michels Fellowship, Heed Fellowship, the Doris P. and Harry I. Wexler Prize, Rosenbaum Research Award, and the Association of University Professors of Ophthalmology/Research to Prevent Blindness Resident and Fellow Research Forum Award. He has participated in multiple National Eye Institute and industry-sponsored clinical trials. At UCSD, Dr. Nudleman's clinical focus is on vitreoretinal diseases and surgery, with a special interest in pediatric vitreoretinopathies. His laboratory focuses on developmental angiogenesis and the role of the Wnt signaling pathway with a particular interest in identifying novel targets to treat vascular diseases.
The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.
The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.
The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.
Click Here To Accept